Beam Therapeutics Inc.

NASDAQ:BEAM

Biotechnology

Healthcare
$20.94 +1.46%

+$0.48 today

Market cap
$2.17B
Beta
2.20
P/E (TTM)
-52.3
EPS (TTM)
-$0.63
52W Low $15.60High $36.44

Volume 4.21M

Average 2.11M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.48B

FY 2025 · Annual

+34.2% YoY

Liabilities

$242.82M

FY 2025 · Annual

-34.4% YoY

Equity

$1.24B

FY 2025 · Annual

+68.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents559.99M232.77M435.9M281.97M294.94M
Short-term Investments405.65M845.37M753.98M568.77M950.27M
Net Receivables300M0000
Inventory00000
Other Current Assets014.76M21.17M27.41M0
Total Current Assets1.27B1.09B1.21B878.15M1.27B
Property, Plant & Equipment (Net)186.98M234.13M237.81M216.28M205.18M
Goodwill00000
Intangible Assets00000
Long-term Investments00006.68M
Tax Assets00000
Other Non-current Assets14.47M14.69M10.87M9.4M634K
Total Non-current Assets201.45M248.82M248.67M225.68M212.49M
Total Assets1.47B1.34B1.46B1.1B1.48B
Account Payables7.47M9.03M1.62M3.87M10.23M
Short-term Debt2.29M00014.36M
Tax Payables00000
Deferred Revenue86.27M135.97M68.71M108.86M6.66M
Other Current Liabilities60.83M49.68M100.69M19.74M36.34M
Total Current Liabilities213.44M223.6M205.57M182.07M96.94M
Long-term Debt3.01M000139.76M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)262.3M202.18M109.89M33.22M0
Other Non-current Liabilities34.16M13.84M3.02M7.04M(133.63M)
Total Non-current Liabilities434.28M384.65M272.82M188.21M145.88M
Total Liabilities647.72M608.24M478.39M370.28M242.82M
Common Stock684K712K816K836K1.02M
Retained Earnings(768.27M)(1.06B)(1.19B)(1.57B)(1.64B)
Accumulated OCI(50K)(2.43M)604K679K1.11M
Other Stockholders Equity00000
Minority Interest00000
Total Equity826.74M733.47M981.33M733.55M1.24B
Total Debt147.64M179.01M172.69M161.43M293.88M
Net Debt(412.35M)(53.76M)(263.21M)(120.54M)(1.06M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$219.8M
Short-term Investments$933.1M
Other Current$25.7M
Total Current Assets$1.2B
PP&E (Net)$193.2M
Other Non-current$14.6M
Total Non-current Assets$207.8M
Total Assets$1.4B

Analysis

Selected assets total $1.4B for Latest. The largest visible component is Short-term Investments at $933.1M, about 67.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
8-KCurrent reportNov 3, 2026
10-QQuarterly reportNov 3, 2026
4Statement of changes in beneficial ownershipOct 16, 2026
4Statement of changes in beneficial ownershipOct 2, 2026

How much cash does BEAM have?

Beam Therapeutics Inc. (BEAM) reported $294.94M in cash and equivalents in fiscal 2025.

How much debt does BEAM carry?

Beam Therapeutics Inc. (BEAM) reported $293.88M of total debt, with net debt of -$1.06M.